October 2009 Editor's Picks: Products from Emerson and Minitab - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

October 2009 Editor's Picks: Products from Emerson and Minitab


Equipment and Processing Report

Featured products from Pharmaceutical Technology's monthly newsletter, Equipment & Processing Report

product Emerson Process Management
Wireless solution enables full redundancy

Emerson Process Management (Austin, TX) now offers full redundancy for Smart Wireless monitoring and control through its DeltaV S-series digital automation system. The enhancements include redundant wireless input–output cards and redundant Smart Wireless remote links. Users can now create a hot backup scheme by installing two remote links in the same space. If the first link fails, the system switches to the second link almost instantaneously. The second link sends data to the control system, thus ensuring the consistent presence of one reliable link. This configuration virtually eliminates data loss resulting from failures.

The DeltaV digital automation system provides process-control and predictive maintenance to enable accurate control decisions. The product also includes a complete set of control algorithms and batching software that allows operators to run processes such as biopharmaceutical batch applications. The DeltaV system offers complete audit trails.


productMinitab
Software enables value-stream mapping

Minitab (State College, PA) offers version 3.2 of its Quality Companion software for managing and executing quality-improvement projects. The software now includes a tool for value-stream mapping (VSM) that helps users find inefficiencies and eliminate waste. The VSM tool facilitates the tracking of variables such as cycle time, lead time, and work-in-progress time and automatically performs timeline calculations to help improve manufacturing, supply-chain, and product-development processes. In addition, the software lets users add custom data and enables data sharing during a project.

Quality Companion has built-in roadmaps to which users can directly add the tools they need. Users also can design their own roadmaps. Project charters, failure mode and effects analysis, fishbone diagrams, and process maps can be created in the software and stored within a roadmap. When a project is complete, users can archive all of their data in a single file that includes records of all actions taken during the project.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
18%
To all process for new products only
13%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Equipment and Processing Report,
Click here